Hi Tangs, I don't regard you as sharp enough to spot the obvious. In case you don't know, the torturous path of drug approval often requires multiple late stage trials. Real scientists like to see results replicated in different labs, areas, patient groups and combinations. To conduct a single trial, then recommend against any further trials, is anti-science. With the pandemic virtually over, it is a moot point IMO. What this thread was started for, is the emerging results on testing the IVM attraction to the spike protein. How that affinity can affect spike proteins invading the body from the vaccine and from Covid. Do you know that excess deaths persisted for over a decade after the 1918-1920 influenza/Spanish Flu epidemic. I think the work being done by Professor Clancy and like groups around the world is very important.
